Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
337.75
-4.07 (-1.19%)
Nov 22, 2024, 4:00 PM EST - Market closed
Medpace Holdings Revenue
Medpace Holdings had revenue of $533.32M in the quarter ending September 30, 2024, with 8.29% growth. This brings the company's revenue in the last twelve months to $2.07B, up 16.24% year-over-year. In the year 2023, Medpace Holdings had annual revenue of $1.89B with 29.17% growth.
Revenue (ttm)
$2.07B
Revenue Growth
+16.24%
P/S Ratio
5.04
Revenue / Employee
$350,994
Employees
5,900
Market Cap
10.47B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.89B | 425.85M | 29.17% |
Dec 31, 2022 | 1.46B | 317.62M | 27.80% |
Dec 31, 2021 | 1.14B | 216.45M | 23.38% |
Dec 31, 2020 | 925.93M | 64.96M | 7.54% |
Dec 31, 2019 | 860.97M | 156.38M | 22.19% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Smith & Nephew | 5.64B |
Encompass Health | 5.22B |
Catalent | 4.42B |
Charles River Laboratories International | 4.06B |
Exact Sciences | 2.69B |
Exelixis | 2.08B |
Sarepta Therapeutics | 1.64B |
Bio-Techne | 1.17B |
MEDP News
- 17 hours ago - The Schall Law Firm Invites Stockholder Participation In An Inquiry Into Medpace Holdings Inc's Possible Securities Law Violations - Accesswire
- 1 day ago - Alert of Investigation of MEDP: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm - Accesswire
- 1 day ago - Medpace Holdings, Inc. Is Being Investigated For Fraud And Investors With Losses Are Encouraged To Reach Out To The Schall Law Firm - Accesswire
- 2 days ago - MEDP Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ:MEDP) Investors with Significant Losses to Contact the Firm - Accesswire
- 2 days ago - The Schall Law Firm Wants Shareholders To Join An Inquiry Into Medpace Holdings Inc For Violating Securities Laws - Accesswire
- 2 days ago - MEDP Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm - PRNewsWire
- 3 days ago - The Schall Law Firm Wants Shareholders To Take Part In An Inquiry Into Medpace Holdings Inc's Securities Law Violations - Accesswire
- 3 days ago - MEDP Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ:MEDP) Investors with Significant Losses to Contact the Firm - Accesswire